Clinical Trial Update: Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial evaluating safety and efficacy of LUM001 in patients with primary sclerosing cholangitis (PSC) has completed with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• LUM001

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Primary Sclerosing Cholangitis (PSC) | Phase 2 | Status: COMPLETED | Results posted: 2017-04-12